Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights Life Science Investing
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors Life Science Investing
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc. Life Science Investing
Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update Life Science Investing
Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Life Science Investing
HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia During IND-Enabling Studies Life Science Investing
MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness Life Science Investing
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer Biotech Investing
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab Life Science Investing
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update Life Science Investing
NRx Pharmaceuticals, Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update Life Science Investing
